The disproportionate excess mortality risk of COVID-19 in younger people with diabetes warrants vaccination prioritisation
Open Access
- 16 February 2021
- journal article
- letter
- Published by Springer Science and Business Media LLC in Diabetologia
- Vol. 64 (5), 1184-1186
- https://doi.org/10.1007/s00125-021-05404-8
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Risks of and risk factors for COVID-19 disease in people with diabetes: a cohort study of the total population of ScotlandThe Lancet Diabetes & Endocrinology, 2020
- Coronavirus vaccine? Join the queueThe Lancet Diabetes & Endocrinology, 2020
- Type 2 Diabetes and COVID-19–Related Mortality in the Critical Care Setting: A National Cohort Study in England, March–July 2020Diabetes Care, 2020
- Living risk prediction algorithm (QCOVID) for risk of hospital admission and mortality from coronavirus 19 in adults: national derivation and validation cohort studyBMJ, 2020
- Use of “normal” risk to improve understanding of dangers of covid-19BMJ, 2020
- Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort studyThe Lancet Diabetes & Endocrinology, 2020
- Associations of type 1 and type 2 diabetes with COVID-19-related mortality in England: a whole-population studyThe Lancet Diabetes & Endocrinology, 2020
- Factors associated with COVID-19-related death using OpenSAFELYNature, 2020
- Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO studyDiabetologia, 2020
- How old are you, really? Communicating chronic risk through ‘effective age’ of your body and organsBMC Medical Informatics and Decision Making, 2016